Shweta Maniar

CIK: 0001850826

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RXST

RxSight, Inc.

Director

OFIX

Orthofix Medical Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RXST
RxSight, Inc.
Jun 17, 2026
Award(A)
Direct
37K shares-
OFIX
Orthofix Medical Inc.
Jun 10, 2026
Award(A)
Direct
15K shares-
OFIX
Orthofix Medical Inc.
Jun 18, 2025
Award(A)
Direct
18.8K shares-
RXST
RxSight, Inc.
Jun 3, 2025
Award(A)
Direct
10.8K shares-
RXST
RxSight, Inc.
Jan 22, 2025
Sale(S)
Direct
3.5K shares at avg. $30.87$109K
RXST
RxSight, Inc.
Nov 26, 2024
Sale(S)
Direct
3.8K shares at avg. $45.88$174K

		Type	Shares	Price		Ownership
Jun 17, 2026	RXST RxSight, Inc.	Award(A)	37,037	-	$0	Direct
Jun 10, 2026	OFIX Orthofix Medical Inc.	Award(A)	14,965	-	$0	Direct
Jun 18, 2025	OFIX Orthofix Medical Inc.	Award(A)	18,841	-	-	Direct
Jun 3, 2025	RXST RxSight, Inc.	Award(A)	10,752	-	-	Direct
Jan 22, 2025	RXST RxSight, Inc.	Sale(S)	3,519	$30.87	$108,618	Direct
Nov 26, 2024	RXST RxSight, Inc.	Sale(S)	3,782	$45.88	$173,518	Direct

1-6 of 6 transactions

About Maniar Shweta

Maniar Shweta (SEC CIK 0001850826) files insider reports with the SEC as Director of RxSight, Inc. (RXST) and Director of Orthofix Medical Inc. (OFIX).

Signal8 holds 6 ownership filings by Maniar Shweta, all Form 4s, filed between Nov 26, 2024 and Jun 18, 2026. Those filings report 6 transactions, from Nov 26, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Maniar Shweta's filings is in LEWISVILLE, TX.

Recent filings by Maniar Shweta

Jun 17, 2026: Grant or award of RXST shares (Form 4, code A).
Jun 10, 2026: Grant or award of OFIX shares (Form 4, code A).
Jun 18, 2025: Grant or award of OFIX shares (Form 4, code A).
Jun 3, 2025: Grant or award of RXST shares (Form 4, code A).
Jan 22, 2025: Open-market sale of RXST shares (Form 4, code S).

Other insiders filing for RxSight, Inc. (RXST)

Weinberg Eric
Wilterding Mark, Chief Financial Officer
Kurtz Ronald M MD, Chief Medical Officer
Goldshleger Ilya, Chief Operating Officer
Mottiwala Aziz, President and CEO
Warner Robert Keith, Director

How to read Form 4 transaction codes